BCN Peptides is focused entirely on the Bulk cGMP manufacture of Bioactive Peptides by Solid Phase Synthesis.
• FDA approved, with no 483.
• The company has been audited by the EDQM and found with cGMP for the manufacture of sterile peptides.
• BCN Peptides holds four Certificates of Suitability of the European Pharmacopoeia.
Our key technologies are:
• Solid Phase Synthesis.
• HPLC Purification.
• Lyophilisation under GMP conditions.
• Sterile Peptides
We concentrate our efforts in the following activities:
• Synthesis under cGMP of Bulk Generic Peptides.
• Custom API Peptides.